People · Operator
Named in public records as an officer, director or promoter · active 2009–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nuclea Biotechnologies, Inc. | — | Biotechnology | Series A | $25.3M | $38.6M | 2009 |
Patrick J. Muraca at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick J. Muraca on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dennis K. Stone | 1 | 3 |
| Richard R. Vietor | 1 | 2 |
| William R. Harman | 1 | 1 |
| Charles P. Stetson | 1 | 1 |
| Paula J. Evans | 1 | 1 |
| James W. Lewis | 1 | 1 |
| Richard W. Vietor | 1 | 1 |
| PAULA C. EVANS | 1 | 1 |
| Robert J. Pierce | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.